Physician profile
David M Ott
NPI 1588660914
$379,602.63
in general payments reported to CMS, 2019-2025
9 companies · $39K in 2025
The $39K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86K · 2020: $72K · 2021: $56K · 2022: $54K · 2023: $42K · 2024: $32K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $112K · Food and Beverage: $550 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $111,824.88 |
| Food and Beverage | $549.83 |
| Education | $169.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $378,555.26 | 2019-2025 | |
| Smith+Nephew, INC. | $292.70 | 2019 | |
| Orthofix Medical, INC. | $195.90 | 2019-2025 | Physio-Stim |
| Fidia Pharma USA INC. | $169.02 | 2025 | Hymovis, Richplat Ortho Prp System |
| Stryker Corporation | $150.82 | 2024 | Mako |
| Depuy Synthes Sales INC. | $117.38 | 2024 | Attune, Emphasys |
| Uoc USA INC | $77.58 | 2025 | U2 Pf+, Psi |
| Si-Bone, INC. | $27.98 | 2024 | |
| Endo Pharmaceuticals INC. | $15.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.